Cellectis (CLLS) Gross Margin (QoQ) (2015 - 2023)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Cellectis | 20.83 Bn | 20.62 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 17,776.00 |
| Sep 30, 2023 | -20,588.00 |
| Jun 30, 2023 | 20,939.00 |
| Mar 31, 2023 | -14,056.00 |
| Dec 31, 2022 | 10,998.00 |
| Sep 30, 2022 | -18,454.00 |
| Jun 30, 2022 | -205.00 |
| Mar 31, 2022 | 7,756.00 |
| Dec 31, 2021 | 1,016.00 |
| Sep 30, 2021 | -567.00 |
| Jun 30, 2021 | -7,336.00 |
| Mar 31, 2021 | 10,478.00 |
| Dec 31, 2020 | -1,004.00 |
| Sep 30, 2020 | 7,437.00 |
| Jun 30, 2020 | -19,175.00 |
| Mar 31, 2020 | 11,861.00 |
| Dec 31, 2019 | -7,764.00 |
| Sep 30, 2019 | 2,060.00 |
| Jun 30, 2019 | -1,418.00 |
| Mar 31, 2019 | 1,782.00 |
| Dec 31, 2018 | 2,143.00 |
| Sep 30, 2018 | -8,473.00 |
| Jun 30, 2018 | -149.00 |
| Mar 31, 2018 | 319.00 |
| Dec 31, 2017 | -348.00 |
| Sep 30, 2017 | 8,749.00 |
| Jun 30, 2017 | -8,776.00 |
| Mar 31, 2017 | -151.00 |
| Dec 31, 2016 | -441.00 |
| Sep 30, 2016 | 4,564.00 |
| Jun 30, 2016 | -4,254.00 |
| Mar 31, 2016 | -220.00 |
| Dec 31, 2015 | 39.00 |
| Sep 30, 2015 | 95.00 |
| Jun 30, 2015 | -28.00 |